Table 3 Treatment efficacy (n=31)
From: Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer
Overall | Intrahepatic | Gallbladder | Extrahepatic | |||||
|---|---|---|---|---|---|---|---|---|
Treatment response | N | % (95%-CI) | N | % | N | % | N | % |
31 | 100 | 14 | 100 | 10 | 100 | 7 | 100 | |
Complete response | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Partial response | 8 | 26 (14–44) | 1 | 7 | 4 | 40 | 3 | 42 |
Stable disease | 14 | 45 (29–62) | 9 | 64 | 3 | 30 | 2 | 29 |
Progressive disease | 9 | 29 (16–47) | 4 | 29 | 3 | 30 | 2 | 29 |
Median TTP (months) | 6.4 | 6.2 | 6.0 | 7.3 | ||||
Median OS (months) | 11.0 | 8.4 | 11.1 | 13.3 | ||||
